Can COVID-19 (Coronavirus Disease 2019) cause bradycardia (abnormally slow heart rate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

COVID-19 Can Cause Bradycardia

Yes, COVID-19 can cause bradycardia as both an acute cardiovascular complication during infection and potentially as a long-term sequela. 1

Mechanisms of COVID-19-Associated Bradycardia

COVID-19 can affect the cardiovascular system through several mechanisms:

  1. Direct viral injury to myocytes or vascular endothelium 1
  2. Inflammatory damage to cardiac pacemaker cells 2
  3. Cytokine effects on the sinoatrial node - high levels of pro-inflammatory cytokines may act directly on the SA node 2
  4. Hypoxia from respiratory involvement 2
  5. Exaggerated response to medications used in COVID-19 treatment 2

Clinical Presentation and Characteristics

  • Bradycardia typically develops during the course of COVID-19 infection, often appearing between days 5-15 of illness 2, 3
  • Heart rates during COVID-19-associated bradycardia typically range from 42-49 beats per minute 2
  • Episodes can last from 1-14 days 2
  • Most cases are self-limiting and resolve without permanent intervention 3
  • Bradycardia can occur in patients with or without pre-existing cardiovascular disease 2

Incidence and Risk Factors

Bradycardia appears to be relatively common in COVID-19 patients:

  • In some studies, more than 1 in 3 patients (37%) receiving remdesivir for COVID-19 developed bradycardia 4
  • Risk factors for developing bradycardia include:
    • Age ≥65 years (OR 1.76) 4
    • Hypertension (OR 1.37) 4
    • Obesity (OR 1.32) 4

Severity and Clinical Significance

Bradycardia in COVID-19 patients can range from mild to severe:

  • Mild bradycardia (51-59 bpm): Most common, occurring in 26.7% of patients in one study 4
  • Moderate bradycardia (41-50 bpm): Occurs in approximately 9.7% of patients 4
  • Severe bradycardia (≤40 bpm): Relatively rare, affecting only about 0.7% of patients 4

Importantly, bradycardia in COVID-19 patients has been associated with:

  • Increased mortality 5
  • Longer hospital stays 5
  • May be a warning sign of an impending cytokine storm 2

Types of Bradyarrhythmias in COVID-19

COVID-19 can cause various forms of bradyarrhythmias:

  • Sinus bradycardia: Most common form 3
  • Complete heart block: Can occur even in patients with preserved left ventricular ejection fraction 6
  • In severe cases, pacemaker insertion may be required (76.3% of severe cases in one review) 6

Management Considerations

For patients with COVID-19 who develop bradycardia:

  • Monitor cardiac function closely, especially in high-risk patients (elderly, those with hypertension or obesity)
  • Most cases are self-limiting and resolve without intervention 3
  • For symptomatic cases, medications like atropine may be used for acute management 3
  • Consider the contribution of medications (though studies show mixed results regarding remdesivir's role in bradycardia) 5, 4
  • Permanent pacemakers may be needed in cases of persistent high-grade AV block 6

Important Clinical Pitfalls

  1. Don't confuse with medication effects - While medications like remdesivir have been implicated, the relationship isn't consistently proven 5
  2. Monitor beyond acute phase - Bradycardia can develop several days into the illness 2
  3. Don't overlook in mild cases - Bradycardia can occur even in patients who don't require ICU care 3
  4. Consider as warning sign - Bradycardia may signal the onset of a serious inflammatory response 2
  5. Follow-up is essential - While most cases resolve, some patients may develop long-term cardiac sequelae 1

COVID-19-associated bradycardia represents one of many potential cardiovascular manifestations of this multisystem disease and warrants careful clinical attention and monitoring.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.